Walker Neal

Avg. Two Year Performance

(94%) Avg. Purchase Return
(39%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return7%18%(11%)(62%)(94%)
Purchase Success Rate1 of 11 of 10 of 10 of 10 of 1
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 30 of 30 of 30 of 30 of 3

Aclaris Therapeutics, Inc.

Other » Other

Interim President and CEO, Director:

Holdings: 1.29M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Aldeyra Therapeutics, Inc.

Drugs » Biotechnology

Director:

Holdings: 15.85K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--